Group 1 - Centrus Energy (NYSE: LEU) has seen its stock nearly quadruple over the past 12 months due to growing demand for nuclear power, new partnerships, contract extensions, and ambitious expansion plans [1] - Centrus Energy is one of the few U.S. companies licensed to sell low-enriched uranium (LEU) and the only publicly listed company producing high-assay low-enriched uranium (HALEU) for advanced nuclear reactors, positioning it well for the nuclear energy market's expansion [3] - The company previously enriched its own LEU but shut down its U.S. plants in 2013, leading to a significant revenue decline from $1.86 billion in 2012 to $514 million in 2014, exacerbated by the Fukushima disaster and falling uranium prices [5][4] Group 2 - After shutting down its domestic plants, Centrus became a middleman, purchasing LEU from overseas and reselling it to domestic utility companies under medium- to long-term contracts, generating predictable recurring revenues [6] - Centrus is currently enriching its own HALEU for small-scale government contracts, which could become a significant growth engine as more utility companies build advanced nuclear reactors [7] - The stock has experienced significant growth as the nuclear energy market recovers, but its rich valuations may limit upside potential in the future [8]
Where Will Centrus Energy (LEU) Stock Be in 1 Year?